See more : BioNxt Solutions Inc. (XPHYF) Income Statement Analysis – Financial Results
Complete financial analysis of Charoen Pokphand Enterprise (Taiwan) Co., Ltd. (1215.TW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Charoen Pokphand Enterprise (Taiwan) Co., Ltd., a leading company in the Packaged Foods industry within the Consumer Defensive sector.
- Teladoc Health, Inc. (0LDR.L) Income Statement Analysis – Financial Results
- Kycom Holdings Co., Ltd. (9685.T) Income Statement Analysis – Financial Results
- Velan Inc. (VLNSF) Income Statement Analysis – Financial Results
- Mayne Pharma Group Limited (MYX.AX) Income Statement Analysis – Financial Results
- Kawasaki & Co., Ltd. (3045.T) Income Statement Analysis – Financial Results
Charoen Pokphand Enterprise (Taiwan) Co., Ltd. (1215.TW)
About Charoen Pokphand Enterprise (Taiwan) Co., Ltd.
Charoen Pokphand Enterprise (Taiwan) Co., Ltd. engages in the agriculture, animal husbandry, and meat businesses in Taiwan and Asia. The company operates through Feed Business Group, Meat Processing Business, Food Processing Business, Egg Chicken Business, and Other segments. It produces and sells feed for chickens, pigs, ducks, cattle, and other animals; develops and sells chicken processed products; and imports and supplies vaccines poultry vaccines, pig vaccines, antimicrobial, feed additives, feed quality raw materials, natural health agents, cleaning and disinfectant products, and diluent for artificial insemination. In addition, it engages in the provision of husbandry management services for chickens to produce eggs and meat; chicken and pig breeding; and electric slaughtering of poultry. The company was formerly known as Taiwan Pokphand Feed Co., Ltd. and changed its name to Charoen Pokphand Enterprise (Taiwan) Co., Ltd. in 1988. The company was founded in 1921 and is based in Taipei City, Taiwan.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 29.16B | 28.96B | 24.84B | 22.19B | 21.17B | 21.24B | 19.87B | 18.17B | 16.55B | 17.53B | 18.12B | 17.77B | 17.68B | 16.40B | 15.24B | 15.41B | 12.69B | 9.67B |
Cost of Revenue | 24.16B | 25.08B | 21.44B | 18.66B | 18.15B | 18.38B | 16.54B | 15.35B | 14.53B | 15.44B | 16.44B | 16.41B | 16.50B | 15.00B | 13.88B | 14.12B | 11.40B | 8.70B |
Gross Profit | 5.00B | 3.88B | 3.40B | 3.52B | 3.02B | 2.86B | 3.33B | 2.82B | 2.03B | 2.09B | 1.69B | 1.36B | 1.18B | 1.40B | 1.36B | 1.29B | 1.29B | 969.81M |
Gross Profit Ratio | 17.15% | 13.39% | 13.69% | 15.88% | 14.27% | 13.46% | 16.75% | 15.52% | 12.25% | 11.91% | 9.30% | 7.65% | 6.68% | 8.52% | 8.95% | 8.37% | 10.20% | 10.03% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 809.64M | 750.75M | 719.78M | 649.03M | 547.96M | 574.52M | 561.46M | 455.64M | 361.71M | 325.72M | 323.95M | 325.25M | 297.25M | 288.48M | 298.61M | 293.45M | 292.20M | 267.80M |
Selling & Marketing | 1.28B | 1.15B | 1.07B | 998.41M | 1.00B | 1.00B | 1.02B | 848.45M | 781.48M | 796.51M | 834.81M | 806.12M | 773.06M | 753.85M | 697.51M | 631.61M | 575.02M | 517.86M |
SG&A | 2.09B | 1.90B | 1.79B | 1.65B | 1.55B | 1.58B | 1.58B | 1.30B | 1.14B | 1.12B | 1.16B | 1.13B | 1.07B | 1.04B | 996.12M | 925.05M | 867.22M | 785.66M |
Other Expenses | 0.00 | 76.73M | 134.61M | 226.61M | 823.68M | 85.86M | 128.38M | 78.82M | 58.71M | 56.38M | 67.78M | 165.20M | 50.46M | 30.72M | 18.66M | 11.14M | 7.95M | 27.72M |
Operating Expenses | 1.99B | 1.88B | 1.80B | 1.62B | 1.56B | 1.57B | 1.58B | 1.29B | 1.14B | 1.11B | 1.15B | 1.13B | 1.07B | 1.04B | 996.12M | 925.05M | 867.22M | 785.66M |
Cost & Expenses | 26.27B | 26.96B | 23.24B | 20.29B | 19.71B | 19.95B | 18.12B | 16.64B | 15.67B | 16.55B | 17.58B | 17.54B | 17.57B | 16.04B | 14.87B | 15.04B | 12.26B | 9.49B |
Interest Income | 2.74M | 711.00K | 359.00K | 902.00K | 31.19M | 279.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.94M | 694.00K | 402.00K | 658.00K | 689.00K | 2.11M | 4.28M |
Interest Expense | 208.59M | 147.43M | 82.04M | 76.79M | 79.95M | 63.30M | 40.05M | 29.54M | 30.40M | 34.49M | 43.05M | 40.76M | 31.09M | 21.91M | 16.63M | 40.30M | 38.92M | 18.69M |
Depreciation & Amortization | 1.06B | 960.00M | 807.42M | 734.25M | 673.16M | 557.75M | 464.18M | 390.73M | 332.78M | 302.36M | 287.01M | 224.81M | 201.93M | 196.00M | 184.83M | 173.41M | 150.83M | 155.48M |
EBITDA | 4.09B | 3.04B | 2.53B | 2.86B | 2.96B | 1.89B | 2.34B | 2.00B | 1.28B | 1.33B | 990.71M | 739.79M | 429.90M | 687.67M | 605.72M | 519.72M | 580.42M | 372.92M |
EBITDA Ratio | 14.03% | 10.46% | 10.24% | 12.91% | 13.96% | 9.08% | 11.78% | 11.01% | 7.71% | 7.60% | 4.94% | 4.05% | 2.43% | 4.21% | 3.97% | 3.37% | 4.51% | 3.84% |
Operating Income | 2.89B | 2.07B | 1.74B | 2.13B | 2.28B | 1.37B | 1.88B | 1.61B | 942.89M | 1.03B | 607.62M | 494.20M | 227.23M | 494.33M | 420.75M | 345.12M | 421.32M | 216.22M |
Operating Income Ratio | 9.91% | 7.14% | 6.99% | 9.61% | 10.78% | 6.46% | 9.44% | 8.86% | 5.70% | 5.88% | 3.35% | 2.78% | 1.29% | 3.01% | 2.76% | 2.24% | 3.32% | 2.24% |
Total Other Income/Expenses | -74.51M | -53.93M | 40.47M | 177.44M | -79.97M | -105.03M | 89.04M | -29.54M | -30.40M | -34.49M | -43.05M | -39.15M | 86.54M | 114.70M | 35.63M | -58.85M | -36.89M | 14.61M |
Income Before Tax | 2.81B | 1.93B | 1.64B | 2.05B | 2.20B | 1.31B | 1.84B | 1.58B | 912.50M | 995.38M | 564.57M | 455.05M | 196.89M | 469.77M | 404.25M | 306.02M | 390.66M | 198.75M |
Income Before Tax Ratio | 9.65% | 6.66% | 6.62% | 9.23% | 10.40% | 6.16% | 9.24% | 8.70% | 5.51% | 5.68% | 3.12% | 2.56% | 1.11% | 2.87% | 2.65% | 1.99% | 3.08% | 2.06% |
Income Tax Expense | 558.48M | 378.07M | 331.09M | 407.07M | 380.42M | 312.79M | 357.91M | 291.52M | 191.41M | 187.13M | 112.84M | 150.22M | 55.53M | 102.81M | 107.32M | 78.04M | 88.97M | 31.12M |
Net Income | 2.27B | 1.56B | 1.36B | 1.66B | 1.46B | 950.73M | 1.43B | 1.26B | 687.77M | 782.89M | 453.08M | 308.63M | 135.76M | 344.67M | 272.62M | 211.75M | 297.06M | 157.56M |
Net Income Ratio | 7.78% | 5.37% | 5.46% | 7.47% | 6.91% | 4.48% | 7.21% | 6.94% | 4.15% | 4.47% | 2.50% | 1.74% | 0.77% | 2.10% | 1.79% | 1.37% | 2.34% | 1.63% |
EPS | 7.70 | 5.28 | 4.60 | 5.62 | 4.97 | 3.23 | 4.86 | 4.28 | 2.34 | 2.65 | 1.54 | 1.09 | 0.46 | 1.17 | 0.92 | 0.72 | 1.01 | 0.54 |
EPS Diluted | 7.69 | 5.27 | 4.59 | 5.61 | 4.96 | 3.22 | 4.85 | 4.27 | 2.33 | 2.65 | 1.54 | 1.09 | 0.46 | 1.17 | 0.92 | 0.72 | 1.01 | 0.54 |
Weighted Avg Shares Out | 294.79M | 294.79M | 294.79M | 294.79M | 294.79M | 294.79M | 294.79M | 294.79M | 294.38M | 294.79M | 294.79M | 294.79M | 294.79M | 294.79M | 294.79M | 294.79M | 294.79M | 294.38M |
Weighted Avg Shares Out (Dil) | 295.15M | 295.09M | 295.12M | 295.21M | 295.16M | 295.04M | 295.09M | 295.17M | 295.53M | 295.13M | 295.10M | 294.79M | 294.79M | 294.79M | 294.79M | 294.79M | 294.79M | 294.38M |
Source: https://incomestatements.info
Category: Stock Reports